426 related articles for article (PubMed ID: 22144699)
1. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
3. [Steroid pulse therapy].
Miura M
Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
[TBL] [Abstract][Full Text] [Related]
4. [Methylprednisolone pulse therapy in Kawasaki disease].
Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
[TBL] [Abstract][Full Text] [Related]
5. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
[TBL] [Abstract][Full Text] [Related]
6. Role of glucocorticoids in Kawasaki disease.
Miura M
Int J Rheum Dis; 2018 Jan; 21(1):70-75. PubMed ID: 29105310
[TBL] [Abstract][Full Text] [Related]
7. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
Inoue Y; Okada Y; Shinohara M; Kobayashi T; Kobayashi T; Tomomasa T; Takeuchi K; Morikawa A
J Pediatr; 2006 Sep; 149(3):336-341. PubMed ID: 16939743
[TBL] [Abstract][Full Text] [Related]
8. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
Miura M; Kohno K; Ohki H; Yoshiba S; Sugaya A; Satoh M
Eur J Pediatr; 2008 Oct; 167(10):1119-23. PubMed ID: 18175148
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T; Kato I; Shiohama T; Abe K; Anzai S; Takeda N; Yamaguchi KI; Kanazawa M; Kurosaki T
Pediatr Int; 2011 Oct; 53(5):729-735. PubMed ID: 21342358
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T; Kobayashi T; Morikawa A; Ikeda K; Seki M; Shimoyama S; Ishii Y; Suzuki T; Nakajima K; Sakamoto N; Arakawa H
J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
[TBL] [Abstract][Full Text] [Related]
11. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
[TBL] [Abstract][Full Text] [Related]
12. Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone.
Ogata S; Ogihara Y; Nomoto K; Akiyama K; Nakahata Y; Sato K; Minoura K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2009 Nov; 66(5):577-84. PubMed ID: 19680167
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
Sundel RP; Baker AL; Fulton DR; Newburger JW
J Pediatr; 2003 Jun; 142(6):611-6. PubMed ID: 12838187
[TBL] [Abstract][Full Text] [Related]
14. Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.
Horinouchi T; Nozu K; Hamahira K; Inaguma Y; Abe J; Nakajima H; Kugo M; Iijima K
BMC Pediatr; 2015 Nov; 15():177. PubMed ID: 26561332
[TBL] [Abstract][Full Text] [Related]
15. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Hung JJ; Chiu CH
Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
[TBL] [Abstract][Full Text] [Related]
16. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Newburger JW; Sleeper LA; McCrindle BW; Minich LL; Gersony W; Vetter VL; Atz AM; Li JS; Takahashi M; Baker AL; Colan SD; Mitchell PD; Klein GL; Sundel RP;
N Engl J Med; 2007 Feb; 356(7):663-75. PubMed ID: 17301297
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
Miura M; Ohki H; Yoshiba S; Ueda H; Sugaya A; Satoh M; Yamagishi H
Arch Dis Child; 2005 Oct; 90(10):1096-7. PubMed ID: 16177169
[No Abstract] [Full Text] [Related]
20. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
Lo MS; Newburger JW
Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
